Karyopharm Therapeutics | KPTI - 매출원가

주가
8.00
매일 변경
-0.16 -1.96%
매월
-8.57%
매년
86.48%
Q2 예상
7.78




매출원가 변화 날짜
AbbVie USD 4.55B 757M 2025-12
Abbott USD 4.92B 535M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Incyte USD 121.18M 22.18M 2025-12
J&J USD 7.97B 689M 2025-12
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.54B 3M 2025-12
Novartis USD 3.54B 7M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Takeda JPY 401.15B 184.07B 2025-12
TG Therapeutics USD 38.14M 10.05M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Xencor USD 61.66M 50.95M 2025-06